Skip to content

Integrated, cross-sectorial psycho-oncology

Integrated, cross-sectorial psycho-oncology - isPO

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00015326
Enrollment
3484
Registered
2018-10-30
Start date
2019-01-15
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, anxiety, psychosocial problems C00-C97

Interventions

Group 1: Stage 1: Consultation by onco-guides (briefing and provision of home-based information material on self-help offers). Group 2: Stage 2: Psychosocial care (activation by a psychosocial special

Sponsors

Universitätsklinikum Köln, Klinik I für Innere Medizin, Bereich Klinische PsychoonkologiePsychoonkologische Versorgungsforschung
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with an initial diagnosis of cancer and whose statutory health insurance has entered into a special care contract with the competent care network within the framework of isPO are included. Moreover, patients should have sufficient knowledge of the spoken and written German language and must be fully contractually capable (capable of making legal decisions).

Exclusion criteria

Exclusion criteria: People who do not have sufficient German skills in spoken and written language. Furthermore, patients are excluded if their clinical situation does not enable them to receive care in the framework of isPO.

Design outcomes

Primary

MeasureTime frame
The primary endpoint are depression and anxiety of patients after 12 months as measured by the Hospital Anxiety and Depression Scale (HADS).

Secondary

MeasureTime frame
Secondary outcomes are: 1. The use of emotion regulation strategies (as measured by the Cognitive-Emotional Engagement with Cancer questionnaire (KEA-K)) and the reduction of psychosocial risks (as measured by the Psychosocial Risks questionnaire (PSR)) related to the cancer, measured at T1, T2, and T3. 2. The structural quality, process quality, and quality of care from the perspective of employees and patients as well as inhibiting and promoting factors of implementation: postal surveys of patients (n = 3,484) on T2 and T3 and project-accompanying focus groups with patients (n = 4); postal surveys of the employees (n ~ 100) as well as project-accompanying focus groups (n = 8) and interviews with employees (n ~ 16). 3. Subgroup analyses: health-related influencing factors on the effectiveness of psycho-oncological care (secondary data analysis of statutory health insurance routine data).

Countries

Germany

Contacts

Public ContactMichael Kusch

Universitätsklinikum Köln, Klinik I für Innere Medizin, Bereich Klinische PsychoonkologiePsychoonkologische Versorgungsforschung

michael.kusch@uk-koeln.de+49(0)221-478-87410

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026